Perfluoroalkyl chemicals and elevated serum uric acid in US adults

Clinical Epidemiology

Volumn 3, Issue 1, 2011, Pages 251-258

  Shankar, Anoop ^a   Xiao, Jie ^a   Ducatman, Alan ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Perfluoroalkyl chemicals; Perfluorooctane sulfonate; Perfluorooctanoic acid; Uric acid

Indexed keywords

CHOLESTEROL; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; URIC ACID;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD ANALYSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GENDER; HEALTH SURVEY; HUMAN; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; UNITED STATES; URIC ACID BLOOD LEVEL;

EID: 80955124068     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S21677     Document Type: Article

References (29)

1. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci. 2007;99:366-394.
2. Steenland K, Fletcher T, Savitz DA. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect.2010;118:1100-1108.
3. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007; 115:1596-1602.
4. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16: 3553-3562.
5. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266: 3008-3011.
6. Lin SD, Tsai DH, Hsu SR. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc. 2006; 69:512-516.
7. Shankar A, Klein R, Klein BE, Nieto FJ. The association between serum uric acid level and long-term incidence of hypertension: Populationbased cohort study. J Hum Hypertens. 2006;20:937-945.
8. Bhole V, Choi JW, Kim SW, de VM, Choi H. Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med. 2010; 123:957-961.
9. Cain L, Shankar A, Ducatman AM, Steenland K. The relationship between serum uric acid and chronic kidney disease among Appalachian adults. Nephrol Dial Transplant. 2010;25:3593-3599.
10. Sinan DO, Kabakci G, Okutucu S, et al. The association between serum uric acid level and coronary artery disease. Int J Clin Pract. 2010;64: 900-907.
11. Terkeltaub RA. Clinical practice. Gout. N Engl J Med. 2003;349: 1647-1655.
12. Sakr CJ, Kreckmann KH, Green JW, Gillies PJ, Reynolds JL, Leonard RC. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med. 2007;49:1086-1096.
13. Sakr CJ, Leonard RC, Kreckmann KH, Slade MD, Cullen MR. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med. 2007;49:872-879.
14. Costa G, Sartori S, Consonni D. Thirty years of medical surveillance in perfluooctanoic acid production workers. J Occup Environ Med.2009;51:364-372.
15. Steenland K, Tinker S, Shankar A, Ducatman A. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ Health Perspect. 2010;118:229-233.
16. Seals R, Bartell SM, Steenland K. Accumulation and clearance of PFOA in current and former residents of an exposed community. Environ Health Perspect. 2011;119:119-124.
17. National Center for Health Statistics-CDC. National Health and Nutrition Examination Survey 2003-2004: reference manuals and reports. Available at: http://www cdc gov/nchs/nhanes/nhanes2003-2004/ nhanes03_04 htm. Accessed Ocober 22, 2010.
18. National Center for Health Statistics-CDC. Procedures for Laboratory Components of NHANES. Available at: http://www cdc gov/nchs/data/ nhanes/nhanes_03_04/blood03_04 pdf. Accessed Ocober 22, 2010.
19. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42: 1206-1252.
20. National Center for Health Statistics-CDC. Laboratory procedure manual for uric acid. Available at: http://www cdc gov/nchs/data/ nhanes/nhanes_03_04/l40_c_met_uric_acid pdf. Accessed Ocober 22, 2010.
21. National Center for Health Statistics-CDC. Analytical and reporting guidelines for NHANES. Available at: http://www cdc gov/nchs/data/ nhanes/nhanes_03_04/nhanes_analytic_guidelines_dec_2005pdf. Accessed Ocober 22, 2010.
22. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811-1821.
23. Olsen GW, Chang SC, Noker PE, et al. A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans. Toxicology. 2009;256:65-74.
24. Karrman A, Domingo JL, Llebaria X, et al. Biomonitoring perfluorinated compounds in Catalonia, Spain: concentrations and trends in human liver and milk samples. Environ Sci Pollut Res Int. 2010;17:750-758.
25. Panaretakis T, Shabalina IG, Grander D, Shoshan MC, DePierre JW. Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. Toxicol Appl Pharmacol. 2001;173:56-64.
26. Yao X, Zhong L. Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. Mutat Res. 2005; 587:38-44.
27. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis. 2000;148:131-139.
28. Eraly SA, Vallon V, Rieg T et al. Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics. 2008; 33:180-192.
29. Nakagawa H, Hirata T, Terada T, et al. Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid. Basic Clin Pharmacol Toxicol. 2008;103:1-8.